Autism Spectrum Disorders; Dr Blaylock Reports #10

  • Rate This

SUMMARY: Autism Spectrum Disorders is a group of Progressive Central Nervous System (CNS) diseases found in children around 3 years of age. Major Medical Reference sources state that the disease has no known cure and no known cause-a terrifying diagnosis for any parent. Is this the Truth?  No. Autism Spectrum Disorders occurred 1 of 10,000 births 40 years ago and now has increased to 1 in 31, and in California, to 1 in 16 births.  It is not genetic, or infectious or neoplastic. It does present in different forms. Dr. Russell Blaylock who has done research and published on this subject for at least 20 years reviews the evidence supporting Immuno-excitotoxicity as the underlying cause of these diseases. Toxins in our environment such as vaccines, with up to 70 given to children during the school years with a high percentage given before the age of 3, and toxins such as aluminum, fluoride, mercury, acetaminophen,  some of which are found in the carrier fluids associated with the vaccine, lead to priming of the microglia in the brain. With a continued series of immunologic assaults on those exposed to these toxins, the immunologic system throughout the body and brain is hypersensitized and leads to a cascading excitotoxic response to other toxic molecules produced in high concentrations by the microglia  in the brain such as Glutamate, which lead  to cell and astrocyte destruction and CNS damage. Microglial scans of the brain show activation of the microglia throughout the brains of autistic children and into adulthood. There are some supplements which can be helpful, if started early in the disease process. Why the denial of treatment? See this video which is 60 minutes, for answers which can effect your family, employees, patients, friends who will look to you for advice. It is a molecular disease process which will become the center of Medical care by 2100. (JIA) PRINT

Speaker
  • James I. Ausman, MD, MA, PhD

    CEO SNI and SNI Digital; Emeritus Professor Neurosurgery

  • Russell Blaylock, MD

    CEO, Theoretical Neuroscience Research